Cerebral blood flow and glucose utilization seven days
After forebrain ischaemia in the rat // Pharmacology. — par 1990. — N 41. — P. 153 – 60.
Rockenstein E., Mallory M., Mante M. et al. Effects of
Cerebrolysin on amyloid-beta deposition in a transgenic
Model of Alzheimer ’ s disease // J. Neural. Transm. Suppl.
— 2002. — N 62. — Р . 327 – 36.
Rockenstein E., Mallory M., Mante M. et al. Effects of
Cerebrolysin in human APP transgenic animal models
Of Alzheimers disease // Neurobiol. Aging. — 2000. — par Vol. 21, N 1S. — P. S168.
Romagnani S. Human TH1 and TH2 subsets: regulation of
differentiation and role in protection and immunopathology //
Int. Arch. Allergy Immunol. — 1992. — N 98. — Р . 279 – 85.
Romagnani S. TH1 and TH2 in human diseases // Clin. Immunol.
Immunopath. — 1996. — N 80. — Р . 225 – 3.
Roеher M. Dose-dependent effects of Cerebrolysin on
Hyperventilation-induced cerebral dysfunction in healthy
Voluntereers // Interner. Bericht. — 1994. — Р . 1 – 4.
Ruether E., Husmann R., Kinzler E. et al. A 28-week, double-
Blind, placebo-controlled study with Cerebrolysin in patients
With mild to moderate Alzheimer ’ s disease // Int. Clin.
Psychopharmacol. — 2001. — N 16 (5). — Р . 253 – 63.
Ruеher E., Ritter R., Apecechea M. et al. Efficacy of peptidergic
Nootropic drug С erebrolysin in senile dementia
Of the Alzheimers type // Pharmacopsychiat. — 1994. — par Vol. 27. — P. 32 – 0.
Ruether E., Ritter R., Apecechea M. et al. Sustained improvements
In patients with dementia of Alzheimer ’ s type (DAT) 6
Months after termination of Cerebrolysin therapy // J. Neural.
Transm. Suppl. — 2000. — Vol. 107, N 7. — Р . 815 – 29.
320. Ruеher E., Moessler H., Windisch M. The MADB Study:
A randomized, doubleblind, placebocontrolled trial with a
Cerebrolysin in Alzheimers disease // Neurobiol. Aging. — par 2000. — Vol. 21, N 1S. — P. S28.
Satou T., Imano M., Akai F. et al. Morphological observation
of effects of Cerebrolysin on cultured neural cells //
Adv. Biosci. — 1993. — N 87. — P. 195 – 96.
Satou Т, Itoh Т, Fujimoto M., Hashlmoto S. Neurotrophiclike
Effects of FPF-1070 on cultured neurons from chick
|
|
|
Embrionic dorsal root ganglia // Jpn. Pharmacol. Ther. — par 1994. — N 22. — P. 205 – 12.
Satou T., Itoh T., Ohde H. et al. Neurotrophic effects of
FPF-1070 (Cerebrolysin (R)) on cultured neurons from
Chicken embryo dorsal root ganglia, ciliary ganglia, and
Sympathetic trunks // J. Neural. Transm. — 2000. — N 107
(11). — Р . 1253 – 262.
324. Sawalischin J. A., Nijasbekowa A. S. Ü ber die Resultate
Der Cerebrolysinbehandlung bei Patienten mit einer
Amyotrophen Lateralsclerose // II Symposium on Cerebrolysin.
— M., 1975. — Р . 79 – 2.
Schmid F. Effects of brain hydrolysates in children with
Multiple handicaps // II Symposium on Cerebrolysin. — par Moscow, 1975. — Р . 58 – 1.
Schwab M., Antonow-Schlorke I., Zwiener U., Bauer R. Brainderived
Peptides reduce the size of cerebral infarction and
Loss of MAP2 immunoreactivity after focal ischemia in rats // J.
Neural. Transm. Suppl. — 1998. — N 53. — Р . 299 – 11.
Schwab M., Bauer R., Zweiner U. Physiological effects
And brain protection by hypothermia and Cerebrolysin
After moderate forebrain ischemia in rats // Exp. Toxicol.
Pathol. — 1997. — Vol. 49. — P. 105 – 16.
Schwab M., Schaller R., Bauer R., Zweiner U. Morphological
Effects of moderate forebrain ischemia combined
With shortterm hypoxia in rats protective effects of Cerebrolysin
// Exp. Toxicol. Pathol. — 1997. — Vol. 49. — par P. 29 – 7.
Shabanov P. D., Ganapolskyi V. P., Zhumasheva A. B., Elistratov
A. A. Metabolic activator trekrezan possesses meteoadaptogenic,
Psychoenergetic and immune modulating
Properties // New technology in medicine and experimental
Biology. Proc. Int. Sci. Pract. Interdiscipl. WorkshoP. Pattaya-
Bangkok, Thailand, 2007. — 2007. — P. 88.
Shimazu S., Tachikawa N., Iwamoto N. et al. // Neurobiology
|
|
|
Of Aging. — 1992. — Vol. 13, Suppl. 1. — P. 50.
Sommer H., Quandt J. Zur Wirkung eines Hirnhydrolysates
Auf zentral-nervoese Strukturen unter Berucksichtigung
Elektronoptischer Ergebnisse // Schweiz.
Arch. Neurol. Neurochir. Psychiat. — 1973. — N 112. — par Р . 373 – 86.
Sotnikova N. Yu., Gromova О А Antioxidative and immunomodulatory
Effect of Cerebrolysin // Тез . всемирного
НУu1095 чНu1067 ЫЕОu1041 БЗu1054 ОРu1067 Ы
Оu1041 БЗu1054 ОРu1067 Ы Пu1054 О Кu1051 ЛИu1053 НИu1063 ЧЕu1057 СКu1054 ОЙФu1040 АРu1052 МАu1050 КОu1051 ЛОu1043 ГИu1048 И ИЛu1045 ЕКu1040 АРu1057 СТu1042 ВЕu1053 ННu1054 ОЙТu1045 ЕРu1040 АПu1048 ИИТu1054 ОМ7/2009/4
Конгресса по клинической и иммунной патологии ,
Сингапур , 1 – декабря 2002 г . — 2002. — С . 217.
Sotnikova N. Yu., Gromova O. A., Novicova E. A. Dual Effect
Of Cerebrolysin in Children with Attention Deficiency
Syndrome with Hyperactivity: Neuroprotection and Immunomodulation
// Rus. J. of Immunology. — 2002. — Vol. 7,
N 4. — Р . 358 – 64.
Sotnikova N. Yu., Gromova О А, Novikova Е А Neuroimmunomodulatory
Дата добавления: 2018-09-22; просмотров: 141; Мы поможем в написании вашей работы! |
Мы поможем в написании ваших работ!